A method of distinguishing prostate cancer from benign prostatic hyperplasia (BPH) is provided. The mathematical combination or ratio of proPSA and BPSA serum or tissue markers may be used for distinguishing benign prostatic hyperplasia (BPH) from prostate cancer. It is the discovery of the present invention...http://www.google.fr/patents/US6423503?utm_source=gb-gplus-shareBrevet US6423503 - Forms of free prostate-specific antigen (PSA) and their association with prostate tissues from prostate peripheral zone and transition zone
Forms of free prostate-specific antigen (PSA) and their association with ...
